Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 498 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Sex, intimacy and cancer – That Cancer Conversation April 28, 2023 Can Using Essential Oils Help Treat Cancer and Its Side Effects? July 13, 2021 ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΕΟΥΣ February 10, 2019 Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer May 24, 2023 Load more HOT NEWS Cancer in My Community: Overcoming Inequities in Care in Argentina How to Get Started With Exercising at Home During Cancer Antitumour Activity and Favourable Safety Demonstrated After Treatment with Nivolumab and... ESMO World Congress on Gastrointestinal Cancer 2022 Barcelona, Spain 29 June...
